Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-17Clinical Trial Results: Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor
A completed clinical trial evaluating reticulocyte hemoglobin content (RET-he) in the management of functional anemia in adults with solid t…
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: A Study of TAK-103 in Adult With Solid Tumors [Phase 1]
Phase 1 study of TAK-103 in adults with solid tumors; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating Revumenib in colorectal cancer and other solid tumors has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Results: Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002) [Phase 1, Phase 2]
Clinical trial results for MK-1200 in participants with advanced solid tumors across Phase 1 and Phase 2 are posted; study completed with sa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of INCB099280 in combination with axitinib in adults with advanced solid tumors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors [Phase 1]
The document reports the completed Phase I trial of TdCyd (4'-Thio-2'-Deoxycytidine) in patients with advanced solid tumors, sponsored by th…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update evaluates natural killer (NK) cell therapy in combination with interleukin for children and young adults with adva…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating dasatinib in combination with bevacizumab for advanced solid tumors has completed. The snippet does not provide r…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients [Phase 1]
Phase I study evaluating KGX101 as a monotherapy and in combination with Envafolimab in patients with advanced or metastatic solid tumors; r…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update reporting the completion of Phase 1 and Phase 2 studies of FF-10502-01 in patients with advanced solid tumors and lymp…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: GTB-5550 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for GTB-5550 in advanced solid tumors. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of Anvumetostat with IDE397 in MTAP-null solid tumors has completed, including MTAP-null non-sm…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors [Phase 1, Phase 2]
An update on a Phase 1/2 clinical trial of a personalized neoantigen cancer vaccine for adults with solid tumors; the study has been complet…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors [Phase 2]
This Phase 2 trial update assesses the safety and efficacy of PRL3-Zumab in patients with solid tumors; the study is currently active but no…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for KIVU-305 in participants with locally advanced or metastatic solid tumors; the study is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T) [Phase 2]
Phase 2 MATCH subprotocol T trial update reports testing vismodegib (GDC-0449) in cancers with SMO or PTCH1 mutations; the study is active b…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating the combination of nilotinib and paclitaxel in adults with relapsed solid t…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of HDM2024 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating HDM2024 in participants with advanced solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CGT4859, an FGFR2/3 inhibitor, for intrahepatic cholangiocarcinoma, cholangiocarcinoma, and other advanced solid tumors; …
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS) [Phase 1, Phase 2]
Basket trial update for IDX-1197 in HRR-mutated solid tumors (VASTUS) across Phase 1 and Phase 2, now completed.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function [Phase 1]
This Phase 1 trial update reports a study comparing blood levels and safety of tazemetostat in participants with advanced cancer and hepatic…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and tolerability of TNG908 in MTAP-deleted solid tumors has been terminated. The sponsor is Tango Therapeu…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine [Phase 2]
A Phase 2 study to assess long-term brigimadlin treatment in people with solid tumors who previously participated in a brigimadlin trial; th…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria [Phase 1]
Phase I pharmacokinetic study of pazopanib in frail elderly patients (SIOG criteria) was terminated; the trial investigated pazopanib in div…